Compare NEA & VEEV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NEA | VEEV |
|---|---|---|
| Founded | 2002 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance/Investors Services | Computer Software: Prepackaged Software |
| Sector | Finance | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.5B | 39.5B |
| IPO Year | N/A | 2013 |
| Metric | NEA | VEEV |
|---|---|---|
| Price | $11.62 | $217.82 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 27 |
| Target Price | N/A | ★ $299.92 |
| AVG Volume (30 Days) | 803.4K | ★ 1.9M |
| Earning Date | 01-01-0001 | 11-20-2025 |
| Dividend Yield | ★ 4.23% | N/A |
| EPS Growth | N/A | ★ 26.69 |
| EPS | N/A | ★ 5.13 |
| Revenue | N/A | ★ $3,080,246,000.00 |
| Revenue This Year | N/A | $17.74 |
| Revenue Next Year | N/A | $12.24 |
| P/E Ratio | ★ N/A | $42.00 |
| Revenue Growth | N/A | ★ 15.96 |
| 52 Week Low | $9.20 | $201.54 |
| 52 Week High | $11.37 | $310.50 |
| Indicator | NEA | VEEV |
|---|---|---|
| Relative Strength Index (RSI) | 54.78 | 20.29 |
| Support Level | $11.45 | $215.30 |
| Resistance Level | $11.65 | $221.51 |
| Average True Range (ATR) | 0.09 | 6.03 |
| MACD | -0.00 | -0.78 |
| Stochastic Oscillator | 62.82 | 8.03 |
Nuveen AMT-Free Municipal Income Fund is a diversified closed-end management investment company. Its investment objective is to provide current income exempt from regular federal income tax and the alternative minimum tax applicable to individuals, by investing in an actively managed portfolio of tax-exempt municipal securities. The company invest in Transportation, Utilities, Healthcare, Education and Civics, and other sectors, with maximum investment in Transportation.
Veeva is the global leading supplier of cloud-based software solutions for the life sciences industry. The company's best-of-breed offerings address operating and regulatory requirements for customers ranging from small, emerging biotechnology companies to departments of global pharmaceutical manufacturers. The company leverages its domain expertise to improve the efficiency and compliance of the underserved life sciences industry, displacing large, highly customized and dated enterprise resource planning systems that have limited flexibility. Its two main products are Veeva CRM, a customer relationship management platform for companies with a salesforce, and Veeva Vault, a content management platform that tackles various functions within any life sciences company.